Blackstone’s next major bet is on a former Merck monoclonal antibody for atopic dermatitis that a new biotech will test for asthma and COPD. The
Eisai is hoping to grow Leqembi sales 13-fold to around $360 million in fiscal year 2024, as it plans “aggressive investment” and looks to expand
Bolt Biotherapeutics is reshuffling to cut costs and extend its cash runway to the second half of 2026. The California biotech said Tuesday afternoon that
Less than a month after revealing pipeline cuts amid disappointing gene therapy sales, BioMarin is now downsizing its team. The biotech said it will lay
Adding nivolumab (Opdivo) to neoadjuvant chemotherapy followed by adjuvant treatment with the PD-1 inhibitor alone significantly increased event-free survival (EFS) for patients with resectable non-small
Treatment with the bleeding reversal agent andexanet (Andexxa) in people with acute intracerebral hemorrhage on factor Xa inhibitors led to less expansion of hematoma volume
HHS temporarily suspended and is proposing to stop all federal funding for EcoHealth Alliance, a research organization that worked on bat coronaviruses in conjunction with
More than 400 physicians from Delaware’s Christiana Hospital, Wilmington Hospital, and Middletown Free-standing Emergency Department — all part of the ChristianaCare health system — filed
Days before Texas Children’s Hospital — the last provider of gender-affirming care in Texas — closed its doors to new patients, a pediatrician handed Jennifer,
One in five women experience mental health and substance use problems during pregnancy and the postpartum period, a member of the Task Force on Maternal